← All stocks

Core Laboratories Inc. /DE/

CLB Net buying

CIK 0001958086 #3007 in the set updated 18 Sep 2026

Bought (120 mo)

$53.90K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$53.90K

+$53.90K against sales at will

By person

13 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bruno Lawrence

Chairman and CEO

$53.90K (1)

—

+$53.90K

262,438

0.5720%

$2.83M

+158.3%

Hill Christopher Scott

SVP & CFO

—

142,354

0.3102%

$1.53M

+73.6%

Carnes Martha Z.

Director

—

54,397

0.1186%

$586.40K

+77.8%

Gresham Gwendolyn

SVP

—

52,527

0.1145%

$566.24K

+53.5%

Klingensmith Harvey Robert

Director

—

50,031

0.1090%

$539.33K

+90.8%

Temeng Kwaku

Director

—

33,597

0.0732%

$362.18K

+243.1%

Murray Katherine

Director

—

29,290

0.0638%

$315.75K

+434.0%

Straughen Michael

Director

—

29,186

0.0636%

$314.63K

+38.3%

Tattoli Mark Damian

SVP, Gen Counsel & Secretary

—

27,764

0.0605%

$299.29K

+433.6%

ANASTASIO CURT

Director

—

23,805

0.0519%

$256.62K

—

Daniels Kevin

CAO & Treasurer

—

15,949

0.0348%

$171.93K

+39.5%

Teo Sow Hang

CAO & Treasurer

—

8,625

0.0188%

$92.98K

+33.3%

MARTINOVICH ROBERT F

Director

—

8,069

0.0176%

$86.98K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Bruno Lawrence

31 Jul 2026

Chairman and CEO

Buy

5,000

$10.78

$53.90K

What was left out

Form 4 filings counted 70

Amendments (4/A) skipped 5

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,043,310

History held since 2 May 2023